In a recent survey gathering 206 responses from industry leaders, we uncovered fascinating insights into 32 distinct RBQM practices. More than half of sponsors and CROs have already embraced RBQM approaches, signaling a transformative shift in how we manage risks in drug development. In our latest webinar featuring Ken Getz of Tufts Center for the Study of Drug Development, we explored these numbers. Now, you can watch on-demand: https://bit.ly/440BWmf 🗣 #ClinicalResearch #RBQM #Pharma #Biotech
CluePoints’ Post
More Relevant Posts
-
Choosing the right trial design approach reduces patient burden, costs and timelines. With the new #Pulmonary Suite, #respiratory studies can be de-risked to speed up the delivery of new medicines to people with unmet need. Learn more at https://lnkd.in/gVkJFWZs. #clinicaltrials #biotech #pharma #COPD #IPF
To view or add a comment, sign in
-
With #healthcaredemand surging due to an aging population and other critical factors, the need to accelerate innovation in #drugdevelopment has never been greater. Thermo Fisher Scientific’s new Accelerator™ Drug Development approach combines #CDMO and #CRO solutions in one streamlined service to bring treatments to patients faster. Learn more about this end-to-end offering for #biotech and #pharma #drugdevelopers in our blog, “Redefining acceleration of the #drugdevelopment journey”: http://spr.ly/6044sALLp
To view or add a comment, sign in
-
Today’s #biotech and #pharma sponsors are facing rising costs, increased competition, and pressure to innovate faster than ever. To stay ahead, maximizing value at every stage of #drugdevelopment is critical—from early-stage research to #clinicaltrials and #commercialization. Join Thermo Fisher Scientific for an upcoming webinar where we’ll share findings from the Tufts Center for the Study of Drug Development for the Study of Drug Development on how integrating end-to-end #CDMO and #CRO services and solutions can significantly boost your program's #expectedNetPresentValue (eNPV). In this webinar, you'll learn: 1️⃣ The benefits of leveraging #eNPV modeling for combined #CDMO and #CRO services 2️⃣ How to streamline processes with #ThermoFisher’s Accelerator™ Drug Development 3️⃣ Real-world case studies showcasing successes from #biotech and #pharma sponsors Led by Dr. Joseph DiMasi from Tufts University, as well as Brenda Bruker and Brittany Hall from Thermo Fisher Scientific, this is a can’t-miss event. RSVP by clicking below: http://spr.ly/6041SlmwD
To view or add a comment, sign in
-
Don't forget to sign up to our webinar to learn how integrating CDMO and CRO services can significantly boost your program's expected Net Present Value
Today’s #biotech and #pharma sponsors are facing rising costs, increased competition, and pressure to innovate faster than ever. To stay ahead, maximizing value at every stage of #drugdevelopment is critical—from early-stage research to #clinicaltrials and #commercialization. Join Thermo Fisher Scientific for an upcoming webinar where we’ll share findings from the Tufts Center for the Study of Drug Development on how integrating end-to-end #CDMO and #CRO services and solutions can significantly boost your program's #expectedNetPresentValue (eNPV). In this webinar, you'll learn: • The benefits of leveraging #eNPV modeling for combined #CDMO and #CRO services • How to streamline processes with #ThermoFisher’s Accelerator™ Drug Development • Real-world case studies showcasing successes from #biotech and #pharma sponsors Led by Dr. Joseph DiMasi from Tufts University, as well as Brenda Bruker and Brittany Hall from Thermo Fisher Scientific, this is a can’t-miss event. RSVP by clicking below: http://spr.ly/6046qxNbm
To view or add a comment, sign in
-
Today’s #biotech and #pharma sponsors are facing rising costs, increased competition, and pressure to innovate faster than ever. To stay ahead, maximizing value at every stage of #drugdevelopment is critical—from early-stage research to #clinicaltrials and #commercialization. Join Thermo Fisher Scientific for an upcoming webinar where we’ll share findings from the Tufts Center for the Study of Drug Development for the Study of Drug Development on how integrating end-to-end #CDMO and #CRO services and solutions can significantly boost your program's #expectedNetPresentValue (eNPV). In this webinar, you'll learn: 1️⃣ The benefits of leveraging #eNPV modeling for combined #CDMO and #CRO services 2️⃣ How to streamline processes with #ThermoFisher’s Accelerator™ Drug Development 3️⃣ Real-world case studies showcasing successes from #biotech and #pharma sponsors Led by Dr. Joseph DiMasi from Tufts University, as well as Brenda Bruker and Brittany Hall from Thermo Fisher Scientific, this is a can’t-miss event. RSVP by clicking below: http://spr.ly/6048Slm9Y
To view or add a comment, sign in
-
Today’s #biotech and #pharma sponsors are facing rising costs, increased competition, and pressure to innovate faster than ever. To stay ahead, maximizing value at every stage of #drugdevelopment is critical—from early-stage research to #clinicaltrials and #commercialization. Join Thermo Fisher Scientific for an upcoming webinar where we’ll share findings from the Tufts Center for the Study of Drug Development on how integrating end-to-end #CDMO and #CRO services and solutions can significantly boost your program's #expectedNetPresentValue (eNPV). In this webinar, you'll learn: • The benefits of leveraging #eNPV modeling for combined #CDMO and #CRO services • How to streamline processes with #ThermoFisher’s Accelerator™ Drug Development • Real-world case studies showcasing successes from #biotech and #pharma sponsors Led by Dr. Joseph DiMasi from Tufts University, as well as Brenda Bruker and Brittany Hall from Thermo Fisher Scientific, this is a can’t-miss event. RSVP by clicking below: http://spr.ly/6044qxNiM
To view or add a comment, sign in
-
Those who missed this engaging panel discussion about the benefits of global clinical supply chain orchestration hosted by Mark Patterson and Fernanda Teles with Novartis, Roche and SAP at the 25th Annual Clinical Trial Supply Europe 2024 Conference, you can watch some of the session highlights in this video recap https://okt.to/Krmp3F #OCTMedDevice #CTSEurope #ClinicalTrials #ClinicalLogistics #Healthcare #Pharma #biotechnology
To view or add a comment, sign in
-
In the recent edition, Top Most Innovative Bioanalytical Service Providers to Watch, Insights Care magazine gladly features Altasciences guided by Lynne LeSauteur, PhD, Vice President of Laboratory Sciences, and other prominent bioanalytical service providers. Read More: https://cutt.ly/ReOHCgwg #BioanalyticalServices #InnovationInHealthcare #Biotech #Pharma #HealthcareInnovation #LaboratoryServices #InsightsCare #healthcareinnovationmagazines #onlinehealthcaremagazine #globalhealthcaremagazines
To view or add a comment, sign in
-
Today’s #biotech and #pharma sponsors are facing rising costs, increased competition, and pressure to innovate faster than ever. To stay ahead, maximizing value at every stage of #drugdevelopment is critical—from early-stage research to #clinicaltrials and #commercialization. Join Thermo Fisher Scientific for an upcoming webinar where we’ll share findings from the Tufts Center for the Study of Drug Development on how integrating end-to-end #CDMO and #CRO services and solutions can significantly boost your program's #expectedNetPresentValue (eNPV). In this webinar, you'll learn: • The benefits of leveraging #eNPV modeling for combined #CDMO and #CRO services • How to streamline processes with #ThermoFisher’s Accelerator™ Drug Development • Real-world case studies showcasing successes from #biotech and #pharma sponsors Led by Dr. Joseph DiMasi from Tufts University, as well as Brenda Bruker and Brittany Hall from Thermo Fisher Scientific, this is a can’t-miss event. RSVP by clicking below: http://spr.ly/6046qxNbm
To view or add a comment, sign in
-
Join our webinar to learn the benefits of combining CRO and CDMO services through ThermoFisher's Accelerator™ Drug Development
Today’s #biotech and #pharma sponsors are facing rising costs, increased competition, and pressure to innovate faster than ever. To stay ahead, maximizing value at every stage of #drugdevelopment is critical—from early-stage research to #clinicaltrials and #commercialization. Join Thermo Fisher Scientific for an upcoming webinar where we’ll share findings from the Tufts Center for the Study of Drug Development on how integrating end-to-end #CDMO and #CRO services and solutions can significantly boost your program's #expectedNetPresentValue (eNPV). In this webinar, you'll learn: • The benefits of leveraging #eNPV modeling for combined #CDMO and #CRO services • How to streamline processes with #ThermoFisher’s Accelerator™ Drug Development • Real-world case studies showcasing successes from #biotech and #pharma sponsors Led by Dr. Joseph DiMasi from Tufts University, as well as Brenda Bruker and Brittany Hall from Thermo Fisher Scientific, this is a can’t-miss event. RSVP by clicking below: http://spr.ly/6046qxNbm
To view or add a comment, sign in
10,220 followers